Dermatomyositis (Inflammation of the Skin, Muscles, and Blood Vessels) in Dogs

  • Occurrence: very rare
  • Location of illness: General/Whole body
Content
Download/Print

Dermatomyositis is an inflammatory condition that affects both the skin, muscles, and blood vessels in dogs. It is genetically determined and often occurs in certain breeds, such as the Collie and Shetland Sheepdog.

The most important facts at a glance

Dermatomyositis in dogs is a complex disease caused by genetic, immunological, and environmental factors. Collies and Shetland Sheepdogs in particular are susceptible due to their genetic predisposition. The disease arises from a malfunction of the immune system that attacks the body’s own tissue, leading to inflammation of the skin and muscles. Environmental factors such as stress or infections can worsen the symptoms. Common symptoms include skin lesions, muscle pain, and hair loss. Diagnosis is made through clinical examinations, skin biopsies, and possibly genetic tests. Corticosteroids and immunosuppressants are used for treatment to control the inflammation and alleviate the symptoms. Supplementary measures such as a balanced diet and gentle exercise are also important. The prognosis depends on the severity of the disease and the response to therapy, with early diagnosis and consistent treatment improving the long-term outlook. Preventive measures include avoiding breeding affected animals and minimizing triggers such as UV light. Regular veterinary check-ups are crucial to monitor the course of the disease and adjust treatment to improve the dog’s quality of life.

Causes

Dermatomyositis in dogs is a complex disease triggered by a combination of genetic, immunological, and environmental factors. Genetic predisposition plays a crucial role, with certain breeds, including Collies and Shetland Sheepdogs, being particularly susceptible. This genetic tendency suggests an autosomal dominant inheritance with incomplete penetrance, meaning that not all dogs carrying the gene develop symptoms.

The disease is characterized by a malfunction of the immune system, in which the immune system mistakenly attacks the body’s own tissue. This leads to inflammation of the skin and muscles. Environmental factors such as stress, infections, or injuries can act as triggers or exacerbating factors by further destabilizing the immune system.

Scientists suspect that the inflammation is triggered by an abnormal response to normal environmental antigens or by direct damage to the tissues. Histological examination of the affected skin and muscles shows inflammatory infiltrates consisting mainly of lymphocytes, supporting the immune-mediated nature of the disease. This inflammatory response leads to the characteristic skin lesions and muscle weakness.

Symptoms

The symptoms of dermatomyositis in dogs can vary, depending on the severity of the disease and the areas affected. The most common symptoms include skin lesions that present as crusts, ulcers, or erosions on the skin surface. These lesions often occur on the face, especially around the eyes and nose, as well as on the ears, tail tip, and limbs.

Another characteristic symptom is muscle weakness, which can manifest as difficulty getting up, walking, or climbing stairs. In severe cases, muscle atrophy, i.e. a loss of muscle mass, can occur. Some dogs also show signs of pain or discomfort, especially when moving.

In addition to the physical symptoms, affected dogs may also show behavioral changes, such as signs of depression or lethargy, which are due to the chronic nature of the disease and the associated discomfort. In some cases, fever may also occur, especially if the disease is accompanied by a secondary infection.

Diagnosis

The diagnosis of dermatomyositis in dogs is based on a combination of clinical signs, history data, and specific diagnostic tests. The veterinarian usually begins with a thorough physical examination of the dog, paying particular attention to skin and muscle abnormalities. The history may provide clues to the genetic predisposition, especially if the dog belongs to one of the susceptible breeds.

A skin biopsy is an important diagnostic test that can help confirm the disease. By taking and microscopically examining skin tissue samples, characteristic inflammatory changes associated with dermatomyositis can be detected. These changes typically include lymphocytic infiltration and degeneration of skin and muscle cells.

In addition, electromyography (EMG) can be performed to assess the electrical activity of the muscles and identify signs of muscle weakness or damage. Blood tests can also be helpful to rule out other possible causes of the symptoms and assess the dog’s general health. In some cases, a genetic test can be performed to confirm the predisposition to dermatomyositis.

Therapy

The treatment of dermatomyositis in dogs aims to alleviate symptoms and slow the progression of the disease. As it is a chronic condition, long-term therapy is required. Corticosteroids, such as prednisone, are often used to suppress the inflammatory response and control symptoms. These medications can help heal the skin lesions and reduce muscle weakness.

In some cases, additional immunosuppressants, such as azathioprine or cyclosporine, may be prescribed to further modulate the immune system and prevent flare-ups of the disease. The dosage of these medications must be carefully monitored and adjusted to minimize side effects.

In addition to drug therapy, supportive measures can be taken to improve the dog’s well-being. These include a balanced diet, regular but gentle exercise to maintain muscle strength, and protecting the skin from excessive sunlight, as UV light can worsen symptoms. In severe cases where skin ulcers occur, special wound care may be required to prevent infection.

Prognosis and follow-up care

The prognosis for dogs with dermatomyositis varies depending on the severity of the disease and the response to treatment. In many cases, the disease is well controlled, and dogs can lead a relatively normal life if properly treated and monitored. Early diagnosis and initiation of therapy can significantly improve the long-term prognosis.

However, some dogs may experience recurrent flare-ups of the disease, especially if therapy is discontinued or not consistently administered. In such cases, the dog’s quality of life may be impaired, and it may be necessary to adjust treatment or pursue additional therapeutic approaches.

In severe cases where muscle damage progresses or secondary complications, such as infections, occur, the prognosis may be less favorable. Close collaboration with the veterinarian and regular check-ups are crucial to monitor the course of the disease and adjust therapy accordingly.

Prevention

Since dermatomyositis is a genetically determined disease, the most important preventive measure is to avoid breeding animals with a known genetic predisposition. Breeders of breeds that are susceptible to dermatomyositis should consider genetic testing and only use animals for breeding that are not carriers of the responsible gene.

For dogs already suffering from dermatomyositis, it is important to minimize triggers and exacerbating factors. This includes protecting the skin from excessive sunlight, as UV light can worsen inflammatory reactions. Stress should be avoided, and the dog’s immune system should be strengthened through a balanced diet and regular exercise.

Regular veterinary check-ups are also important to monitor the dog’s health and react early to changes. Through close collaboration with the veterinarian and adherence to the recommended treatment and prevention strategies, the risk of disease flare-ups can be minimized, and the quality of life of the affected dog can be improved.

Content
Download/Print